The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone

被引：0
|
作者：
Constance Delaby
Teresa Estellés
Nuole Zhu
Javier Arranz
Isabel Barroeta
María Carmona-Iragui
Ignacio Illán-Gala
Miguel Ángel Santos-Santos
Miren Altuna
Isabel Sala
M. Belén Sánchez-Saudinós
Laura Videla
Sílvia Valldeneu
Andrea Subirana
Mireia Tondo
Francisco Blanco-Vaca
Sylvain Lehmann
Olivia Belbin
Rafael Blesa
Juan Fortea
Alberto Lleó
Daniel Alcolea
机构：
[1] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,Sant Pau Memory Unit, Department of Neurology
[2] Universitat Autònoma de Barcelona,Servei de Bioquímica i Biologia Molecular
[3] IRMB,undefined
[4] INM,undefined
[5] Université de Montpellier,undefined
[6] INSERM,undefined
[7] CHU de Montpellier,undefined
[8] Laboratoire de Biochimie-Protéomique clinique,undefined
[9] Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas,undefined
[10] CIBERNED,undefined
[11] Fundació Catalana Síndrome de Down,undefined
[12] Centre Mèdic Down,undefined
[13] Servei de Bioquímica,undefined
[14] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,undefined
[15] Universitat Autònoma de Barcelona,undefined
[16] Unversitat Autònoma de Barcelona,undefined
[17] Centro de Investigación Biomédica en Red en Diabetes y Enfermedades Metabólicas (CIBERDEM),undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
Amyloid; Aβ1–40; Aβ1–42; Cerebrospinal fluid; Tau; Biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The Recombinant Amyloid-β Peptide Aβ1-42 Aggregates Faster and Is More Neurotoxic than Synthetic Aβ1-42
    Finder, Verena H.
    Vodopivec, Ivana
    Nitsch, Roger M.
    Glockshuber, Rudi
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 396 (01) : 9 - 18
  • [22] Total-tau, Aβ1-42 and Ubiquitin in CSF in the diagnosis of Alzheimer disease
    Iqbal, K
    EUROPEAN PSYCHIATRY, 2002, 17 : 76S - 76S
  • [23] Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias
    Baiardi, Simone
    Abu-Rumeileh, Samir
    Rossi, Marcello
    Zenesini, Corrado
    Bartoletti-Stella, Anna
    Polischi, Barbara
    Capellari, Sabina
    Parchi, Piero
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (02): : 263 - 273
  • [24] Plasma p-tau181/A beta(1-42) ratio predicts A beta-PET status and correlates with CSF-p-tau181/A beta(1-42) and future cognitive decline
    Fowler, Christopher J.
    Stoops, Erik
    Rainey-Smith, Stephanie R.
    Vanmechelen, Eugeen
    Vanbrabant, Jeroen
    Dewit, Nele
    Mauroo, Kimberley
    Maruff, Paul
    Rowe, Christopher C.
    Fripp, Jurgen
    Li, Qiao-Xin
    Bourgeat, Pierrick
    Collins, Steven J.
    Martins, Ralph N.
    Masters, Colin L.
    Doecke, James D.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2022, 14 (01)
  • [25] CSF Aβ1–42, but not p-Tau181, Predicted Progression from Amnestic MCI to Alzheimer’s Disease Dementia
    Liara Rizzi
    Luciane Missiaggia
    Matheus Roriz-Cruz
    NeuroMolecular Medicine, 2018, 20 : 491 - 497
  • [26] Why is the C-terminus of Aβ(1-42) more unfolded than that of Aβ(1-40)?: Clues from hydrophobic interaction
    Shen, Liang
    Ji, Hong-Fang
    Zhang, Hong-Yu
    JOURNAL OF PHYSICAL CHEMISTRY B, 2008, 112 (10): : 3164 - 3167
  • [27] Effects of processing and storage conditions on CSF amyloid β (1-42) and tau concentrations:: Implications for use in clinical practice
    Blankenstein, MA
    Schoonenboom, NSM
    Mulder, C
    Vanderstichele, H
    van Elk, EJ
    Kok, A
    Van Kamp, GJ
    Scheltens, P
    CLINICA CHIMICA ACTA, 2005, 355 : S217 - S217
  • [28] CSF Aβ1-42, but not p-Tau181, differentiates aMCI from SCI
    Rizzi, Liara
    Portal, Marcelle Maria
    Alves Batista, Carlos Eduardo
    Missiaggia, Luciane
    Roriz-Cruz, Matheus
    BRAIN RESEARCH, 2018, 1678 : 27 - 31
  • [29] Stability of CSF β-amyloid1-42 and tau levels by APOE genotype in Alzheimer patients
    Huey, Edward D.
    Mirza, Nadeem
    Putnam, Karen T.
    Soares, Holly
    Csako, Gyorgy
    Levy, James A.
    Copenhaver, Brittany
    Cohen, Robert M.
    Sunderland, Trey
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 22 (01) : 48 - 53
  • [30] Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF
    Hulstaert, F
    Blennow, K
    Ivanoiu, A
    Schoonderwaldt, HC
    Riemenschneider, M
    De Deyn, PP
    Bancher, C
    Cras, P
    Wiltfang, J
    Mehta, PD
    Iqbal, K
    Pottel, H
    Vanmechelen, E
    Vanderstichele, H
    NEUROLOGY, 1999, 52 (08) : 1555 - 1562
12345